And

are now a part of the new and improved

Advertisement

Dermwire News

News | April 29, 2019

Higher BMI Linked to Psoriasis

Excess weight is a contributing factor for developing psoriasis, and the greater the body mass index (BMI), the higher the chance of getting the disease, according to a new study. To investigate the causal relationship between BMI and...

Read More

News | May 23, 2019

FDA Approves Sorilux for Adolescent Plaque Psoriasis

The FDA has approved Mayne Pharma Group Limited's Sorilux (calcipotriene) Foam, 0.005% in adolescents 12 years and older. The FDA approved Sorilux in 2010 based on evidence from two eight-week placebo controlled clinical trials in...

Read More

News | May 7, 2019

Aesthetic Innovations Summit Coming to New Orleans

Coming off an impressive inaugural meeting in 2018, the second annual Aesthetics Innovation Summit will unite over 300 of the most influential corporate, capital, and clinical leaders in New Orleans to collaborate on the development and...

Read More

News | April 28, 2019

Xstrahl Introduces UpGraded Treatment System for Non-Melanoma Skin Cancer

Xstrahl Medical is launching its latest superficial radiotherapy treatment system to treat the full range of non-melanoma skin cancer cases.  The new Xstrahl 150 system offers several features that enhance the capabilities of...

Read More

News | May 16, 2019

Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIA

Nestlé has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale of Nestlé Skin Health for a value of CHF 10.2 billion....

Read More

Advertisement

The Latest News

Advertisement

View more

Advertisement